Ulorin is a recombinant human insulin injection, which is mainly used to maintain blood glucose levels in diabetic patients. Recombinant Human Insulin Injection is mainly used for the treatment of diabetic patients who need to rely on insulin to maintain blood glucose levels, and it is also suitable for the early treatment of early diabetic patients, diabetic patients during pregnancy, this product can also be used for treatment. Patients may experience adverse reactions such as hypoglycemia, local redness, swelling or itching, systemic allergy, skin subsidence or tissue enlargement or thickening at the injection site after using this product. Patients with hypoglycemia, patients allergic to the product is prohibited. It is recommended that patients who need to use recombinant human insulin injection, go to a regular hospital, under the guidance of the doctor to regulate the use of medication.